0001104659-24-031942.txt : 20240307
0001104659-24-031942.hdr.sgml : 20240307
20240307170207
ACCESSION NUMBER: 0001104659-24-031942
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rajah Vignesh
CENTRAL INDEX KEY: 0001815042
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 24731097
MAIL ADDRESS:
STREET 1: HENRIKSHOJ 8
STREET 2: ROOM 4
CITY: VEDBAEK
STATE: G7
ZIP: DK-2950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
4
1
tm248257-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-05
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001815042
Rajah Vignesh
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE, SUITE 3350
NEW YORK
NY
10169
0
1
0
0
SVP & CHIEF MEDICAL OFFICER
0
Common Stock
2024-03-05
4
S
0
1711
16.53
D
33889
D
Common Stock
4266
I
By Spouse and minor
Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.
This transaction was executed in multiple trades at prices ranging from $16.52 to $16.555, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 4,033 shares of common stock owned by Reporting Person's spouse and 233 held by Reporting Person's minor child. Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship.
Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act, as amended, or for any other purpose.
/s/ John LaRocca, Attorney-in-Fact
2024-03-07